Clonal evolution and lack of cytogenetic response are adverse prognostic factors for hematologic relapse of chronic phase CML patients treated with imatinib mesylate (Q44598251)
Jump to navigation
Jump to search
scientific article published on 25 September 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clonal evolution and lack of cytogenetic response are adverse prognostic factors for hematologic relapse of chronic phase CML patients treated with imatinib mesylate |
scientific article published on 25 September 2003 |
Statements
1 reference
Clonal evolution and lack of cytogenetic response are adverse prognostic factors for hematologic relapse of chronic phase CML patients treated with imatinib mesylate (English)
1 reference
1 reference
Michael J Mauro
1 reference
Carolyn Blasdel
1 reference
Melanie Farnsworth
1 reference
Gwen Kurilik
1 reference
Yi-Ching Hsieh
1 reference
Motomi Mori
1 reference
25 September 2003
1 reference
Identifiers
1 reference